Boston Millennia Portfolio Company, Histogenics Corp., Announces Peter Greenleaf as CEO

10 June, 2013

Histogenics Corp. has announced the appointment of Peter Greenleaf to Chief Executive Officer. Mr. Greenleaf brings over 20 years of experience in the biotechnology industry, most recently as President of MedImmune, the worldwide biologics arm of AstraZeneca.